Healthy Talk: Filling the Language Gap
- Disease/Condition
- Infections and Infestations; Infections and Infestations
- Primary sponsor
- Rhodes University
- Funder
- VLIR UOS; NIHSS
- Location
- South Africa
- Phase
- Phase 3
- Start date
- Jan 01, 1900
- End date
- Jan 01, 1900
Communication resources have been developed to assist healthcare professionals communicate with patients in cases where there are language barriers. This trial is part of a PhD study, for which the research questions are:1. How do healthcare providers and healthcare users communicate when they are not fluent in the same language?2. What communication resources and training are appropriate for healthcare provision in South Africa?3. What are the effects of the suggested communication resources and training in healthcare provision?In order to answer these research questions, the following objectives have been identified:1. To identify the main communication problems experienced by healthcare providers and healthcare users.2. To identify the main communication strategies used by healthcare providers and healthcare users.3. To create and implement communication resources and training for healthcare providers to use in the provision of HIV/AIDS and TB consultations.4. To analyse the effects of these communication resources and training in terms of satisfaction and feasibility of implementation.This trial focuses on research questions 2 and 3, and objectives 3 and 4.
- Registry
- Pan Africa Clinical Trials Registry
- Trial ID
- PACTR202204533305867
- Type
- Non-Device Trial
Access comprehensive clinical trial information for PACTR202204533305867 through Pure Global AI's free database. This Phase 3 trial is sponsored by Rhodes University and is currently Recruiting. The study focuses on Infections and Infestations; Infections and Infestations.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.